Keros Therapeutics (KROS) Net Margin (2019 - 2025)
Keros Therapeutics posted quarterly Net Margin of 4066.03% for Q4 2025, down 1312627.0% year-on-year from N/an in Q4 2024, and down 7865.62% on a QoQ basis from 51.04% in Q3 2025.
Keros Therapeutics (KROS) has 6 years of Net Margin data on file, last reported at 4066.03% in Q4 2025.
- For the quarter ending Q4 2025, Net Margin fell 1312627.0% year-over-year to 4066.03%; the trailing twelve-month figure through Dec 2025 stood at 35.62% (down 15609188.0% YoY), and the FY2025 full-year result was 35.65%, changed N/A from the prior year.
- Net Margin for Q4 2025 stood at 4066.03%, down from 51.04% in the prior quarter.
- Across five years, Net Margin topped out at 9060.24% in Q4 2024 and bottomed at 493000.0% in Q3 2023.
- The 5-year median for Net Margin is 168.96% (2025), against an average of 49612.82%.
- The widest annual swing landed in 2024, when Net Margin soared 47935155 bps; it then plunged 1312627 bps in 2025.
- A 5-year view of Net Margin shows it stood at 38.77% in 2021, then plunged by 247 bps to 134.37% in 2022, then tumbled by 20844 bps to 28141.96% in 2023, then surged by 132 bps to 9060.24% in 2024, then plunged by 145 bps to 4066.03% in 2025.
- The last three Net Margin figures came in at 4066.03% (Q4 2025), 51.04% (Q3 2025), and 168.96% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | -4,066.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,066.03% |
| Sep 30, 2025 | -51.04% |
| Jun 30, 2025 | -168.96% |
| Mar 31, 2025 | 70.27% |
| Dec 31, 2024 | 9,060.24% |
| Sep 30, 2024 | -13,648.45% |
| Dec 31, 2023 | -28,141.96% |
| Sep 30, 2023 | -493,000.00% |
| Mar 31, 2022 | -134.37% |
| Dec 31, 2021 | -38.77% |
| Jun 30, 2021 | -15,622.00% |
| Dec 31, 2019 | -128.04% |
| Sep 30, 2019 | -159.96% |
| Jun 30, 2019 | -132.12% |
| Mar 31, 2019 | -145.32% |